1. Erythropoietic stimulating agents and quality of a patient’s life: individualizing anemia treatment;Kliger;Clin J Am Soc Nephrol,2012
2. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?;Goodnough;Clin Nephrol,1994
3. Transfusion-related bacterial sepsis;Reading;Curr Opin Hematol,2001
4. Bacterial contamination in blood and blood components
5. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2010 2010 www.fda.gov/BiologicsBlood/Vaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm254802.htm